n.moreau

TL2 Moderator · Konya

Contributes reviews on supplier material. Based in Konya.

Joined 5 February 2025 · last posted 1d

73 posts, newest first. Showing up to 150.

Tracking a shortage from primary sources rather than rumour — the long version Replied, post #3 · marked as the solution · Access › Shortages · 27 Jul 2026 · 15 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #25 · Analytics › COA interpretation · 25 Jul 2026 · 12 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #8 · Compounds › Repair & healing peptides · 20 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #96 · Compounds › Semaglutide · 8 Jul 2026 · 0 likes Picking up post #93: that is the part I would want checked first. The STEP programme populations were selected: enrollment criteria required baseline body mass index…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #26 · Compounds › Retatrutide · 29 Jun 2026 · 0 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #60 · Evidence › Journal club · 24 Jun 2026 · 3 likes post #59 answers the question as asked. The question underneath it is different. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to…
Submitting a sample: the process end to end Replied, post #25 · Sourcing › Independent verification · 19 Jun 2026 · 24 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Bioimpedance and hydration: why the number moves Replied, post #58 · Outcomes › Body composition · 10 Jun 2026 · 4 likes Worth separating two things that post #54 runs together. Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking…
Racemisation and why it is invisible to a mass measurement Replied, post #15 · Analytics › Impurities & related substances · 9 Jun 2026 · 29 likes Coming back to post #13, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #32 · Compounds › Repair & healing peptides · 27 May 2026 · 15 likes post #31 answers the question as asked. The question underneath it is different. The absence of adequately powered published randomised human trials is the central fact…
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #19 · Evidence › Trials · 10 May 2026 · 3 likes Coming back to post #17, because the follow-up matters more than the original answer. Open-label design: unblinded trials admit expectation effects. For weight-loss…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #44 · Meta › Announcements · 10 May 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #38 · Outcomes › Body composition · 23 Apr 2026 · 24 likes Picking up post #35: that is the part I would want checked first. Maintenance phase: tracking body composition during maintenance (weight stable) is different from…
CJC-1295 with and without DAC: what the modification does Replied, post #31 · Compounds › Secretagogues & GH axis · 11 Apr 2026 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Evidence quality in the secretagogue literature is honestly weaker than in the incretin…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #23 · Analytics › Impurities & related substances · 2 Apr 2026 · 0 likes Worth separating two things that post #19 runs together. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects…
Preprint servers and what screening they do Replied, post #90 · Evidence › Preprints · 15 Mar 2026 · 3 likes post #89 answers the question as asked. The question underneath it is different. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #78 · Clinical › Bloodwork · 16 Feb 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #64 · Outcomes › Progress reports · 16 Feb 2026 · 2 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
MHRA statements, read directly Replied, post #78 · Regional › UK & Ireland · 29 Jan 2026 · 6 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
Request: export my own posts — one year on Replied, post #36 · Meta › Feature requests · 20 Jan 2026 · 16 likes Worth separating two things that post #32 runs together. Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
Designing a personal experiment that could change your mind — one year on Replied, post #2 · Research Methods › N-of-1 designs · 12 Jan 2026 · 21 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #14 · Practice › Administration · 12 Jan 2026 · 9 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #81 · Practice › Side effects · 12 Jan 2026 · 0 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
IGF-1 as a surrogate endpoint and its limitations Replied, post #6 · Compounds › Secretagogues & GH axis · 8 Jan 2026 · 22 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
Tracking that stops updating and then resumes — the long version Replied, post #53 · Sourcing › Logistics · 18 Dec 2025 · 12 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #69 · Clinical › Special populations · 18 Dec 2025 · 21 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #17 · Data & Tools › Calculators · 24 Nov 2025 · 0 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #15 · Compounds › Retatrutide · 23 Nov 2025 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
The anatomy of a question that gets answered within an hour — the long version Replied, post #133 · Start Here › How to Ask · 23 Nov 2025 · 0 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #63 · Pharmacology › Receptor biology · 7 Nov 2025 · 20 likes On post #59 — agreed on the reasoning, with one qualification. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors.…
Dead volume across syringe and needle combinations Replied, post #19 · Devices › Syringes & needles · 3 Nov 2025 · 27 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #5 · Compounds › Oral incretins · 1 Nov 2025 · 18 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
A preprint whose numbers changed substantially at publication Replied, post #69 · Evidence › Preprints · 27 Sep 2025 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #125 · Access › Insurance & coverage · 18 Sep 2025 · 0 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #117 · Data & Tools › Calculators · 15 Sep 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #2 · Analytics › HPLC & UHPLC · 14 Sep 2025 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this…
Power cut for eleven hours: how I assessed it afterwards Replied, post #37 · Practice › Storage & stability · 28 Aug 2025 · 0 likes Coming back to post #35, because the follow-up matters more than the original answer. Published stability data applies specifically to the formulation studied, under…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #39 · Start Here › How to Ask · 15 Aug 2025 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
Meeting a protein target on a suppressed appetite Replied, post #15 · Nutrition & Training › Protein & intake · 13 Aug 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #8 · Evidence › Preprints · 12 Aug 2025 · 1 like This follows post #5 rather than contradicting it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors…
How to research a compound with no human data without deceiving yourself Replied, post #109 · Compounds › Other compounds · 4 Aug 2025 · 1 like Coming back to post #107, because the follow-up matters more than the original answer. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 16 Jul 2025 · 19 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
Lipase elevation without symptoms: the interpretation problem Replied, post #3 · Clinical › Bloodwork · 11 Jul 2025 · 1 like Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #131 · Compounds › Tirzepatide · 8 Jul 2025 · 0 likes I read post #129 twice before replying, because I had assumed the opposite. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others…
Repeatability versus intermediate precision Replied, post #127 · Analytics › Method validation · 3 Jul 2025 · 7 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #43 · Compounds › Semaglutide · 26 Jun 2025 · 9 likes On post #39 — agreed on the reasoning, with one qualification. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the…
Repeatability versus intermediate precision Replied, post #38 · Analytics › Method validation · 22 Jun 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Half-life, steady state, and accumulation worked through Replied, post #128 · Pharmacology › Pharmacokinetics · 16 Jun 2025 · 4 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
A report I filed that turned out to be wrong, and the correction Replied, post #54 · Sourcing › Vendor reports · 15 May 2025 · 17 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
A claim built entirely on a subgroup analysis Replied, post #26 · Evidence › Study critique · 9 May 2025 · 3 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
Which panel is worth repeating and which is worth ignoring Replied, post #14 · Clinical › Bloodwork · 6 May 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Reading a chromatogram someone posted without axes Replied, post #29 · Analytics › HPLC & UHPLC · 5 May 2025 · 12 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #13 · Clinical › Bloodwork · 16 Apr 2025 · 21 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
Holding a dose indefinitely: is there a documented downside? Replied, post #16 · Practice › Dosing & titration · 5 Apr 2025 · 0 likes Picking up post #13: that is the part I would want checked first. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #35 · Compounds › Secretagogues & GH axis · 2 Apr 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Why cagrilintide alone is discussed so much less than in combination Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 3 likes Coming back to post #39, because the follow-up matters more than the original answer. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
A page that has drifted out of date and needs a maintainer Replied, post #77 · Documentation › Wiki requests · 17 Mar 2025 · 3 likes Worth separating two things that post #73 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Retatrutide dose escalation in the published trials Replied, post #20 · Compounds › Retatrutide · 17 Mar 2025 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #59 · Sourcing › Vendor reports · 16 Mar 2025 · 1 like Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
Distinguishing a deletion sequence by mass alone Replied, post #5 · marked as the solution · Analytics › Mass spectrometry · 20 Jan 2025 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Follow-up: Individual participant data versus aggregate data Replied, post #85 · Evidence › Meta-analyses · 11 Jan 2025 · 30 likes Worth separating two things that post #81 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
What changed in 2026, by region Replied, post #18 · Access › International · 11 Dec 2024 · 11 likes post #17 answers the question as asked. The question underneath it is different. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
Revisiting: Moderation log format change Replied, post #53 · Meta › Announcements · 4 Dec 2024 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #33 · Clinical › Special populations · 22 Nov 2024 · 0 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #34 · Sourcing › Regulatory · 20 Nov 2024 · 24 likes I read post #32 twice before replying, because I had assumed the opposite. Research-use-only status is a legal classification, not a safety classification. It means the…
EMA product information as a primary source — does this still hold? Replied, post #38 · Regional › European Union · 15 Nov 2024 · 1 like I read post #36 twice before replying, because I had assumed the opposite. Cross-border purchase rules: buying a prescription in one EU country and bringing it home is…
Why "any advice?" is the least effective ending for a post Replied, post #38 · Start Here › How to Ask · 15 Nov 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #100 · Compounds › Other compounds · 7 Nov 2024 · 12 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
About the International category Replied, post #9 · Access › International · 9 Oct 2024 · 16 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Progressive overload when the scale is falling — one year on Replied, post #114 · Nutrition & Training › Resistance training · 2 Oct 2024 · 16 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Reporting a discrepancy without making an allegation Replied, post #61 · Sourcing › Vendor reports · 7 Sep 2024 · 0 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #15 · Practice › Administration · 25 Aug 2024 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Blind submission and why it changes minds Replied, post #11 · Sourcing › Independent verification · 8 Jul 2024 · 10 likes Picking up post #8: that is the part I would want checked first. Repeat testing: if you want to verify the same lot a second time, testing with a different service…